Squarepoint Ops LLC Astrazeneca PLC Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Squarepoint Ops LLC holds 142,034 shares of AZN stock, worth $9.28 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

142,034

Previous 22,367 535.02%

Holding current value

$9.28 Million

Previous $1.74 Million 534.58%

% of portfolio

0.02%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $9.17 Million - $10.5 Million	119,667 Added 535.02%	142,034 $11.1 Million
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $1.29 Million - $1.57 Million	19,367 Added 645.57%	22,367 $1.74 Million
Q1 2024 May 15, 2024	SELL	$61.03 - $69.57 $31.2 Million - $35.6 Million	-511,817 Reduced 99.42%	3,000 $203,000
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $24 Million - $26.8 Million	387,316 Added 303.77%	514,817 $34.7 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $4.57 Million - $4.96 Million	65,387 Added 105.27%	127,501 $9.13 Million
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $2.77 Million - $3.14 Million	-43,818 Reduced 41.36%	62,114 $4.31 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $88,850 - $115,451	1,639 Added 1.57%	105,932 $7.18 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $3.58 Million - $9.17 Million	67,533 Added 183.71%	104,293 $5.72 Million
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $2.18 Million - $2.62 Million	36,760 New	36,760 $2.43 Million
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $2.02 Million - $2.43 Million	-36,241 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $1.08 Million - $1.28 Million	20,082 Added 124.28%	36,241 $2.11 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $897,794 - $982,305	16,159 New	16,159 $971,000
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $5.12 Million - $6.37 Million	-105,788 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$47.16 - $54.44 $2.39 Million - $2.76 Million	50,720 Added 92.1%	105,788 $5.26 Million
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $918,774 - $1.1 Million	18,936 Added 52.41%	55,068 $2.75 Million
Q3 2020 Nov 16, 2020	SELL	$53.07 - $61.1 $3.43 Million - $3.95 Million	-64,706 Reduced 64.17%	36,132 $1.98 Million
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $4.35 Million - $5.58 Million	100,838 New	100,838 $5.33 Million
Q1 2020 May 15, 2020	SELL	$37.79 - $51.33 $7.46 Million - $10.1 Million	-197,493 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$42.46 - $50.46 $2 Million - $2.38 Million	47,207 Added 31.41%	197,493 $9.85 Million
Q3 2019 Nov 14, 2019	BUY	$40.12 - $45.47 $1.97 Million - $2.24 Million	49,157 Added 48.61%	150,286 $6.7 Million
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $3.77 Million - $4.22 Million	101,129 New	101,129 $4.18 Million
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $410,015 - $497,010	-11,553 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$36.86 - $41.49 $425,843 - $479,333	11,553 New	11,553 $439,000
Q4 2017 Feb 14, 2018	SELL	$32.09 - $34.78 $1 Million - $1.09 Million	-31,204 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $903,667 - $1.06 Million	31,204	31,204 $1.06 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Astrazeneca PLC Transaction History